Understanding Women's Health Status: Normal vs Optimal Ranges

?What is Women's Health Status?

Women's health encompasses a comprehensive assessment of physical, mental, and reproductive wellness specific to female physiology and life stages. This includes evaluation of hormonal balance, cardiovascular health, bone density, metabolic function, and screening for conditions that disproportionately affect women. Regular monitoring across these domains supports early detection of disease and optimisation of long-term health outcomes.

!Why It Matters

Women experience unique health challenges across different life stages, including menstrual irregularities, pregnancy complications, menopause symptoms, and higher rates of autoimmune conditions. Proactive health assessment may help identify risk factors for cardiovascular disease, osteoporosis, and hormonal imbalances that could significantly impact quality of life and longevity.

Reference Ranges

Lab normal ranges may vary between laboratories. Optimal and longevity targets are based on research literature and should be interpreted with your physician.

Symptoms of Imbalance

• Irregular or absent menstrual cycles
• Hot flashes, night sweats, or mood changes during menopause
• Persistent fatigue or low energy
• Bone pain or increased fracture risk
• Anxiety, depression, or cognitive changes

How to Improve Your Levels

• 1Maintain regular gynaecological check-ups and age-appropriate cancer screenings
• 2Engage in weight-bearing and resistance exercise to support bone and cardiovascular health
• 3Ensure adequate intake of iron, calcium, and vitamin D through diet or supplementation
• 4Manage stress through mindfulness, meditation, or counselling
• 5Monitor hormonal markers if experiencing irregular cycles or menopausal symptoms
• 6Maintain a balanced diet rich in whole foods and limit processed foods and excess sodium

When to Test

Baseline health assessments should begin in early adulthood; screening frequency increases with age and individual risk factors. Key testing windows include before pregnancy, during perimenopause (typically ages 40–55), and annually after age 65. Additional testing may be warranted if symptoms arise or family history suggests elevated risk.

Related Biomarkers